(uroporphyrin + heptacarboxylic porphyrins)/coproporphyrin ratios, at least partly ascribable to increased uroporphyrinogen I synthetase (EC 4.3.1.8) activity in patients' hemolysates, and also to a relative deficiency of uroporphyrinogen decarboxylase. Examination of the pattern of porphyrins produced from porphobilinogen by hemolysates is a suitable technique for detecting asymptomatic individuals with porphyria cutanea tarda.
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Porphyria cutanea tarda (PCT)2 is a disease usually manifest in adult life as blistering and increased fragility of areas of the skin exposed to sunlight. Biochemically,
PCT is characterized by marked increases in uro-and heptacarboxylic porphyrins in the urine, and some increase in urinary excretion of hexa-, pentacarboxylicand coproporphyrin (1, 2) . Large amounts of isocoproporphyrin are present in the feces (3) . The cause of the disease is not completely understood.
PCT is associated with exposure to alcohol (4, 5) , estrogens (6, 7), iron excess (8) , and polyhalogenated aromatic hydrocarbons such as hexachlorobenzene (9, 10) vinyl chloride (11), and 2,3,7,8-tetrachlorodibenzodioxin (12) . Liver disease, ranging from chronic hepatitis to cirrhosis or hepatoma, is often present (13) (14) (15) . All this suggests that PCT is an acquired disease.
On the other hand, several authors (4, (16) (17) (18) (19) (20) (17, 18) . Neither of these reagents is readily available. We therefore decided to examine the possibility that the pattern of porphyrins produced from porphobilinogen (PBG) by erythrocyte hemolysate might be characteristic of PCT and of use in family studies.
Materials and Methods
Materials. Kieselgel 60(70-230 mesh) and Merckosorb SI 100 (20 tm particle diameter) were obtained from Merck, Darmstadt,
F.R.G.
The methyl esters of protoporphyrin, coproporphyrin I, and uroporphyrin I were obtained from Sigma Chemical Co., St. Louis, MO 63178; their purity was checked by measuring the molar absorptivity in chloroform by spectrophotometry and also by "high-pressure" liquid chromatography.
The various porphyrins formed in the assays were quantitated by the latter method as their methyl esters. Because methyl ester standards of hepta-, hexa-, and pentacarboxylic porphyrins were not available, we standardized pentacarboxyl porphyrin against the coproporphyrin methyl ester, and the hepta-and hexaporphyrins against the uroporphyrin methyl ester.
It is essential that fluorometer readings be appropriately standardized and calibrated with porphyrin solutions of known concentrations and molar absorptivities (24) . All other reagents used were of analytical grade.
Methods. Heparinized venous blood was washed three
times with isotonic saline (NaCl, 9 g/L) at 4#{176}C; the buffy coat was discarded. The erythrocytes were hemolyzed by freezethawing four times. The hemolysate, 0. 25 stopped by freezing in a mixture of acetone and solid CO2.
After the hemolysate was lyophilized overnight, we dissolved the residue in 1 mL of chloroform, added 5 mL of a solution of concd. H2S04 in methanol (100 mL/L), and incubated the mixture for 60 mm in the dark at 37 #{176}C. We then added 10 mL of water, transferred the solution to a separatory funnel, and added chloroform to give a total volume of 35 mL. The two phases were vigorously mixed and centrifuged, and the water (upper) phase was removed. To neutralize the chloroform phase, we added 8 mL of a 50 g/L solution of NaHCO3 in water, and gently mixed. The procedure was re- Fig. 5 .
peated if the pH of the water phase was <7. The chloroform phase was then washed twicewith10 mL of water, filtered over paper, and evaporated under reduced pressure at room temperature.
The porphyrin methyl esters so produced were then dissolved in chloroform and applied to a silica gel column (Merckosorb SI 100, 20-iim particle size; Merck) for high- 
Patients.
We examined members of four generations of the families of two young women with PCT. The symptoms of PCT had become manifest while the patients were taking oral contraceptives.
At the time of our investigation they had no symptoms, having stopped oral contraceptives and having been treated by repeated phlebotomy, but they showed the typical biochemical abnormalities of PCT in their urine.
Normal values were obtained for 10 ostensibly healthy subjects who were clearly free of PCT.
Results
The urine analysis of the two propositae (patients 5 and 6), who as we have said were clinically in remission, showed the typical pattern of PCT, with a predominant increase in uroand heptacarboxyl-porphyrin (Table 1) members had a slight increase of uroporphyrins and heptacarboxyl porphyrins in urine.
After incubation of hemolysates with PBG, a mixture of uro-, heptacarboxyl, hexacarboxyl-, pentacarboxyl-, and coproporphyrin was observed. There was a marked difference between the patterns for the normal controls and the patterns for the PCT patients and some of their relatives (Figure 1 ). For the normal persons the ratio of uroporphyrin plus heptacarboxylto coproporphyrin is 2.42 (SD = 0.45) and of uroporphyrin to coproporphyrin 1.52 (SD = 0.32). In the PCT group both these ratios were significantly greater (Figure 2) . In this test system we demonstrated alsoa significant decrease in mean URO-D activity, but there was some overlap between normals and PCT subjects (Figure 3) . Mean uroporphyrin I synthetase activity was significantly increased in the PCT group (Figure 4 ), but also in this case there was some overlap.
Each of these parameters alone will not safely discriminate between PCT and normals because of this overlap, but the ratio of porphyrins as described above can be used to discriminate between normals and persons with latent POT who have minimal or no abnormalities in urine porphyrin excreNormals PCI Fig. 4 . Uroporphyrinogen I synthetase activity In erythrocytes (asmeasured by total porphyrin production) In normals and PCT subjects The difference between the mean values of normals and PCT subjects is statistIcally signIficant (p <0.01, Wlicoxon test) tion, for there was no overlap between these groups.
In this family we couldestablish the diagnosis of POT in one of these forms in members of each of three generations ( Figure  5 ).
Discussion
The increased ratio of uroporphyrin to coproporphyrin and of uro-plus heptacarboxyl porphyrins to coproporphyrin formed on incubation of hemolysates from PCT patients with
PBGcanpartly be explained by a decrease in URO-D activity.
Moreover, in the POT group, uroporphyrin I synthetase activity was high as compared with normals, in agreement with Brodie eta!. (25) . These facts together can explain the relative increase in uro-and heptacarboxylic porphyrins seenin POT. An increase in uroporphyrinogen I synthetase activity is also observed in liver tissue in hexachlorobenzene-induced POT in rats (26 addition to clinical examination and biochemical analysis of urine. In our family study, eight persons in the POT groups had abnormal urinary porphyrin excretion rates, while two had only a slight increase in heptacarboxyl porphyrin excretion. In subjects with only slight or no changes in urinary porphyrin excretion rates, this test will provide a diagnosis. This is important because it has consequences for these carriers.
Use of alcohol and of oral contraceptives is contraindicated. Because of the relative simplicity of using PBG as substrate, this test may be substituted for more complex procedures in the investigation of POT patients and their families.
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